Laminitis is a major health concern, especially in horses and ponies who are overweight. It’s one of the most serious and debilitating conditions affecting the equine population, which can quickly ...

New veterinary treatment targets insulin dysregulation, the most common cause of laminitis in horses and ponies Bracknell, United Kingdom – Boehringer Ingelheim has announced the availability in Great ...

Joint injections that contain corticosteroids, such as triamcinolone acetonide, are a common anti-inflammatory in an equine veterinarian's toolbox to treat pain and swelling from conditions like ...

Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis ...

Boehringer Ingelheim has launched Scovella (velagliflozin oral solution) for the treatment of insulin dysregulation (ID) in horses and ponies. With the ...